Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

Oryzon Genomics S.A. (ORN.SG)

2.6950
+0.0150
+(0.56%)
At close: April 22 at 8:09:02 AM GMT+2
Loading Chart for ORN.SG
  • Previous Close 2.6800
  • Open 2.6950
  • Bid 2.8900 x --
  • Ask 2.9750 x --
  • Day's Range 2.6950 - 2.6950
  • 52 Week Range 1.3780 - 3.6050
  • Volume 0
  • Avg. Volume 133
  • Market Cap (intraday) 151.599M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: ORN.SG

View More

Performance Overview: ORN.SG

Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .

YTD Return

ORN.SG
83.58%
IBEX 35... (^IBEX)
12.77%

1-Year Return

ORN.SG
43.35%
IBEX 35... (^IBEX)
19.47%

3-Year Return

ORN.SG
7.80%
IBEX 35... (^IBEX)
50.37%

5-Year Return

ORN.SG
59,788.89%
IBEX 35... (^IBEX)
93.62%

Compare To: ORN.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ORN.SG

View More

Valuation Measures

Annual
As of 4/21/2025
  • Market Cap

    176.98M

  • Enterprise Value

    180.29M

  • Trailing P/E

    --

  • Forward P/E

    15.41

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.79

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    216.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ORN.SG

View More

Company Insights: ORN.SG

Research Reports: ORN.SG

View More